Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.

Chronic granulomatous disease (CGD), an often fatal syndrome of recurrent infections results from the inability of patients' peripheral blood phagocytic leukocytes to generate superoxide despite otherwise normal phagocytic functions such as ingestion and degranulation. Circulating granulocytes and monocytes are the progeny of bone marrow progenitor cells, colony-forming units in culture. We compared the function of cells grown in two different in vitro cuture systems from the bone marrow of a CGD patient with those from normal subjects. The cells of normal colony-forming unit in culture colonies grown in semisolid medium reduced nitroblue tetrazolium dye when stimulated by phorbol myristate acetate; none of the cells from colonies derived from CGD marrow did so. Cells grown in liquid suspension culture from normal marrow generated superoxide nearly as well as normal peripheral blood granulocytes; those from CGD marrow produced no superoxide, similarly cultured cells from both normal and CGD marrow ingested opsonized bacteria at rates equal to peripheral blood granulocytes. CGD marrow-derived cells showed increased exocytic degranulation relative to both normal marrow-derived cells and normal peripheral blood granulocytes. These studies demonstrate that the basic functional characteristics of CGD are embedded in the genetic program of granulocyte progenitors.

[1]  P. Newburger,et al.  Dissociation of opsonized particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line , 1980, The Journal of cell biology.

[2]  P. Newburger,et al.  Activity and activation of the granulocyte superoxide-generating system. , 1980, Blood.

[3]  B. Zakhireh,et al.  Development of Oxidase activity by human bone marrow granulocytes. , 1979, Blood.

[4]  P. Newburger,et al.  Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation , 1979, The Journal of cell biology.

[5]  B. Andersen,et al.  Defective initiation of oxidative metabolism in polymorphonuclear leukocytes. , 1979, New England Journal of Medicine.

[6]  J. White,et al.  An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips. , 1979, American journal of clinical pathology.

[7]  J. Allen,et al.  Autooxidation as a basis for altered function by polymorphonuclear leukocytes. , 1977, Blood.

[8]  A. Goldman,et al.  Undetected carrier state in chronic granulomatous disease. , 1972, The Journal of pediatrics.

[9]  G. Hodgson,et al.  The Growth of Bone Marrow Cells in Liquid Culture , 1972, British journal of haematology.

[10]  T. Stossel,et al.  Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome. , 1972, The New England journal of medicine.

[11]  B. Pike,et al.  Human bone marrow colony growth in agar‐gel , 1970, Journal of cellular physiology.

[12]  D. Nathan,et al.  Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. , 1969, The Journal of clinical investigation.